The Contraceptive Drugs and Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Drugs (Oral Contraceptives, Topical Contraceptives, Contraceptive Injectable), By Device (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, IUD, Others), By Gender (Male, Female).
The Contraceptive Drugs and Devices market in 2024 addresses the global demand for pharmaceuticals and medical devices designed to prevent unwanted pregnancies and promote family planning. Contraceptive options include oral contraceptives, intrauterine devices (IUDs), contraceptive implants, patches, vaginal rings, and barrier methods such as condoms and diaphragms. Market dynamics are driven by factors such as increasing awareness of reproductive health, advancements in contraceptive technology, and the growing trend towards long-acting reversible contraceptives (LARCs). Collaboration between pharmaceutical companies, medical device manufacturers, healthcare providers, and policymakers drives innovation and market growth in contraceptive drugs and devices, enabling individuals to make informed choices about their reproductive health and family planning.
A significant trend in the Contraceptive Drugs and Devices market is the increasing demand for Long-Acting Reversible Contraceptives (LARCs). LARCs, including intrauterine devices (IUDs) and contraceptive implants, offer extended duration of protection against unintended pregnancies with high efficacy rates. This trend is driven by factors such as greater awareness about LARCs, improved access to healthcare services, and the convenience of long-term contraceptive options. As individuals seek reliable and convenient birth control methods, the popularity of LARCs continues to rise, influencing market dynamics and product preferences in the contraceptive market.
The primary driver for the Contraceptive Drugs and Devices market is the increasing global population and the growing awareness of family planning. With rising populations in many regions worldwide, there is a growing emphasis on reproductive health and family planning initiatives to address population growth, promote maternal and child health, and empower individuals to make informed choices about their reproductive futures. This demographic trend, coupled with government-sponsored family planning programs and initiatives by healthcare organizations and NGOs, drives the demand for contraceptive drugs and devices. As governments and healthcare providers prioritize family planning services, the market for contraceptives experiences sustained growth.
An opportunity in the Contraceptive Drugs and Devices market lies in the expansion of male contraceptive options. While female contraceptives have traditionally dominated the market, there is a growing recognition of the need for more diverse contraceptive choices for men. Innovations in male contraceptive methods, such as hormonal contraceptives, non-hormonal contraceptives, and novel delivery systems, present an opportunity for manufacturers to address this unmet need and capture a larger market share. By investing in research and development to develop safe, effective, and reversible male contraceptives, companies can tap into a potentially lucrative market segment and contribute to greater gender equity in family planning options.
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
AbbVie (Allergan PLC)
Agile Therapeutics
Ani Pharmaceuticals Inc
Bayer AG
Church & Dwight Co. Inc
Fuji Latex Co. Ltd
Johnson & Johnson Ltd
Organon
Pfizer Inc
Reckitt Benckiser
Teva Pharmaceuticals Ltd
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Contraceptive Drugs and Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Contraceptive Drugs and Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Contraceptive Drugs and Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Contraceptive Drugs and Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Contraceptive Drugs and Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Contraceptive Drugs and Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Contraceptive Drugs and Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Contraceptive Drugs and Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Contraceptive Drugs and Devices Market Industry
4.2 Key Market Trends in Contraceptive Drugs and Devices Market Industry
4.3 Potential Opportunities in Contraceptive Drugs and Devices Market Industry
4.4 Key Challenges in Contraceptive Drugs and Devices Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Contraceptive Drugs and Devices Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Contraceptive Drugs and Devices Market Outlook By Segments
7.1 Contraceptive Drugs and Devices Market Outlook by Segments
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
8 North America Contraceptive Drugs and Devices Market Analysis And Outlook To 2030
8.1 Introduction to North America Contraceptive Drugs and Devices Markets in 2024
8.2 North America Contraceptive Drugs and Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Contraceptive Drugs and Devices Market size Outlook by Segments, 2021-2030
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
9 Europe Contraceptive Drugs and Devices Market Analysis And Outlook To 2030
9.1 Introduction to Europe Contraceptive Drugs and Devices Markets in 2024
9.2 Europe Contraceptive Drugs and Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Contraceptive Drugs and Devices Market Size Outlook By Segments, 2021-2030
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
10 Asia Pacific Contraceptive Drugs and Devices Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Contraceptive Drugs and Devices Markets in 2024
10.2 Asia Pacific Contraceptive Drugs and Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Contraceptive Drugs and Devices Market size Outlook by Segments, 2021-2030
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
11 South America Contraceptive Drugs and Devices Market Analysis And Outlook To 2030
11.1 Introduction to South America Contraceptive Drugs and Devices Markets in 2024
11.2 South America Contraceptive Drugs and Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Contraceptive Drugs and Devices Market size Outlook by Segments, 2021-2030
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
12 Middle East And Africa Contraceptive Drugs and Devices Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Contraceptive Drugs and Devices Markets in 2024
12.2 Middle East and Africa Contraceptive Drugs and Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Contraceptive Drugs and Devices Market size Outlook by Segments, 2021-2030
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AbbVie (Allergan PLC)
Agile Therapeutics
Ani Pharmaceuticals Inc
Bayer AG
Church & Dwight Co. Inc
Fuji Latex Co. Ltd
Johnson & Johnson Ltd
Organon
Pfizer Inc
Reckitt Benckiser
Teva Pharmaceuticals Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
The global Contraceptive Drugs and Devices Market is one of the lucrative growth markets, poised to register a 7.4% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
AbbVie (Allergan PLC), Agile Therapeutics, Ani Pharmaceuticals Inc, Bayer AG, Church & Dwight Co. Inc, Fuji Latex Co. Ltd, Johnson & Johnson Ltd, Organon, Pfizer Inc, Reckitt Benckiser, Teva Pharmaceuticals Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume